دورية أكاديمية
Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M)
| العنوان: | Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M) |
|---|---|
| المؤلفون: | Aravind, S. R.Aff1, Aff2, Singh, Kiran P., Aquitania, Grace, Mogylnytska, Liliia, Zalevskaya, Alsu G., Matyjaszek-Matuszek, Beata, Wernicke-Panten, Karin, Nguyên-Pascal, My-Liên, Pierre, Suzanne, Rotthaeuser, Baerbel, Kramer, Daniel, Mukherjee, BhaswatiAff10, IDs13300022012557_cor12 |
| المصدر: | Diabetes Therapy: Research, treatment and education of diabetes and related disorders. 13(5):1053-1071 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 18696953 18696961 |
|---|---|
| DOI: | 10.1007/s13300-022-01255-7 |